{"id":1273,"date":"2020-09-16T16:54:26","date_gmt":"2020-09-16T14:54:26","guid":{"rendered":"https:\/\/euroleuk.com\/?page_id=1273"},"modified":"2020-09-16T17:30:05","modified_gmt":"2020-09-16T15:30:05","slug":"jazz-pharmaceuticals-symposium","status":"publish","type":"page","link":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/","title":{"rendered":"Jazz Pharmaceuticals Symposium"},"content":{"rendered":"

\"\"<\/h2>\n

Laying the Foundations for Long Term Remission in H<\/strong>igh-Risk AML*<\/strong><\/h3>\n

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)<\/strong><\/span><\/p>\n

Thursday 29th<\/sup> October, 12:30 \u2013 13:00<\/p>\n\n\n\n\n\n\n
Duration<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker<\/strong><\/td>\n<\/tr>\n
2 mins<\/td>\nWelcome and Introduction<\/td>\nProf Alessandro Isidori, Italy<\/td>\n<\/tr>\n
24 mins<\/td>\nLaying the Foundation for Long Term Remission in High-Risk AML*<\/td>\nDr Donal McLornan, UK<\/td>\n<\/tr>\n
4 mins<\/td>\nSummary and Close<\/td>\nProf Alessandro Isidor, Italy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

This symposium is funded and organised by Jazz Pharmaceuticals.
\nThis symposium will contain promotional content and prescribing information will be shown at the end of each presentation and at the end of the symposium.<\/em><\/strong><\/p>\n

\u00a0<\/em><\/strong>This symposium is intended for healthcare professionals only.<\/em><\/strong><\/p>\n\n\n\n
\n

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national\u00a0<\/strong>reporting system.<\/strong><\/p>\n

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com<\/a> or\u00a0<\/strong>by fax to +44 (0) 1865 598765<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Laying the Foundations for Long Term Remission in High-Risk AML* *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC) Thursday 29th October, 12:30 \u2013 13:00 Duration Title Speaker 2 mins Welcome and Introduction Prof Alessandro Isidori, Italy 24 mins Laying the Foundation for Long Term Remission in High-Risk AML* Dr Donal […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"yoast_head":"\nJazz Pharmaceuticals Symposium - Euroleuk2020<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jazz Pharmaceuticals Symposium - Euroleuk2020\" \/>\n<meta property=\"og:description\" content=\"Laying the Foundations for Long Term Remission in High-Risk AML* *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC) Thursday 29th October, 12:30 \u2013 13:00 Duration Title Speaker 2 mins Welcome and Introduction Prof Alessandro Isidori, Italy 24 mins Laying the Foundation for Long Term Remission in High-Risk AML* Dr Donal […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Euroleuk2020\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-16T15:30:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C-300x54.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/\",\"url\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/\",\"name\":\"Jazz Pharmaceuticals Symposium - Euroleuk2020\",\"isPartOf\":{\"@id\":\"https:\/\/euroleuk.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C-300x54.png\",\"datePublished\":\"2020-09-16T14:54:26+00:00\",\"dateModified\":\"2020-09-16T15:30:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage\",\"url\":\"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C.png\",\"contentUrl\":\"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C.png\",\"width\":1500,\"height\":268},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/euroleuk.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jazz Pharmaceuticals Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/euroleuk.com\/#website\",\"url\":\"https:\/\/euroleuk.com\/\",\"name\":\"Euroleuk2020\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/euroleuk.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jazz Pharmaceuticals Symposium - Euroleuk2020","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Jazz Pharmaceuticals Symposium - Euroleuk2020","og_description":"Laying the Foundations for Long Term Remission in High-Risk AML* *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC) Thursday 29th October, 12:30 \u2013 13:00 Duration Title Speaker 2 mins Welcome and Introduction Prof Alessandro Isidori, Italy 24 mins Laying the Foundation for Long Term Remission in High-Risk AML* Dr Donal […]","og_url":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/","og_site_name":"Euroleuk2020","article_modified_time":"2020-09-16T15:30:05+00:00","og_image":[{"url":"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C-300x54.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/","url":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/","name":"Jazz Pharmaceuticals Symposium - Euroleuk2020","isPartOf":{"@id":"https:\/\/euroleuk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage"},"image":{"@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C-300x54.png","datePublished":"2020-09-16T14:54:26+00:00","dateModified":"2020-09-16T15:30:05+00:00","breadcrumb":{"@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#primaryimage","url":"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C.png","contentUrl":"https:\/\/euroleuk.com\/wp-content\/uploads\/sites\/31\/2020\/08\/Jazz_Pharma_4C.png","width":1500,"height":268},{"@type":"BreadcrumbList","@id":"https:\/\/euroleuk.com\/jazz-pharmaceuticals-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/euroleuk.com\/"},{"@type":"ListItem","position":2,"name":"Jazz Pharmaceuticals Symposium"}]},{"@type":"WebSite","@id":"https:\/\/euroleuk.com\/#website","url":"https:\/\/euroleuk.com\/","name":"Euroleuk2020","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/euroleuk.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/1273"}],"collection":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/comments?post=1273"}],"version-history":[{"count":23,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/1273\/revisions"}],"predecessor-version":[{"id":1299,"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/pages\/1273\/revisions\/1299"}],"wp:attachment":[{"href":"https:\/\/euroleuk.com\/wp-json\/wp\/v2\/media?parent=1273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}